Are you a resident doctor interested in AI and dermatology? We’re hosting an evening at our offices for resident doctors to showcase projects exploring AI across dermatology
Register to attend
On Wednesday 4th February, the Department of Health and Social Care and NHS England published it’s “National Cancer Plan for England: Delivering world class cancer
Jersey GP Surgery introduces Skin Analytics’ AI as a medical device DERM to offer patients earlier diagnosis and avoid unnecessary referrals to specialist services. First
Human Bytes has entered a strategic partnership with UK based Skin Analytics to bring the world’s only autonomous AI for assessment and triage of suspected
Skin Analytics has partnered with UK-based private medical insurance provider Freedom Health to support the launch of Freedom Dermatology, available to all Freedom Health members
Following NICE’s conditional approval of DERM, our Class III CE-marked AI as a medical device for skin cancer detection, a new video feature in Nature
As seen at Affidea.com Affidea, a leading pan-European provider of community-based polyclinics, advanced diagnostics, and multi-specialist care, including oncology, has entered a strategic partnership with Skin
While the NHS 10-Year Health Plan highlights that by 2028 AI skin cancer pathways will be standard of care, this is not the timeline for adoption. Rather this timeline aligns with the expected timing to mandated adoption across the NHS.
Neil Daly, CEO & founder of Skin Analytics, appeared before the UK Parliament’s Science, Innovation and Technology Committee as part of the ongoing inquiry titled: “Innovation Showcase: Reviewing the UK Science and Tech Landscape.”
Residents in Barking & Dagenham now have faster, more accurate access to skin cancer checks thanks to a new partnership between Skin Analytics and Together First CIC, the borough’s GP Federation.
We are absolutely delighted to share that our collaborative work with NHS partners has been recognised with two prestigious awards at the HSJ Digital Awards!
Bridgewater Community Healthcare NHS Foundation Trust and Warrington and Halton Teaching Hospitals NHS Foundation Trust are using the latest in AI technology to provide patients with a swifter diagnosis of skin cancer.
With 19,000 patients supported, we look back on 5 incredible years since Bupa launched a home-based service for skin cancer assessments with Skin Analytics.
Skin Analytics took home the award for AI Company of the Year at the British Data Awards 2025.
On May 1st 2025, the National Institute for Health and Care Excellence (NICE) published its Early Value Assessment (EVA) of ‘Artificial intelligence (AI) technologies for assessing and triaging skin lesions within the urgent suspected skin cancer pathway’.
In this patient story, Giles shares his skin health journey through the decades and how he felt when a suspicious lump on his left temple led him to experience AI for skin cancer detection.
Clinical AI Lead at Skin Analytics, Dr Dilraj Kalsi presented how DERM is at least as good as dermatologists at safely ruling out melanoma at the American Academy of Dermatology
Skin Analytics has secured £15 million in Series B funding led by Intrepid Growth Partners.
Dr Alice Plant, Consultant Dermatologist at University Hospitals Dorset NHS Foundation Trust, and Dr Dilraj Kalsi, Clinical AI Lead at Skin Analytics joined Future Medicine AI Hub to discuss how AI is proving to transform NHS dermatology services.
Register for this HSJ webinar to hear how primary and secondary care organisations across Suffolk and North East Essex ICB worked in partnership to deploy DERM.
From sceptic to strong supporter: why I believe everyone should have access to AI skin cancer assessments.
Following the implementation of DERM, Kingston and Richmond NHS Foundation Trust have been shortlisted for two HTN awards – Best use of AI for diagnosis, treatment and patient care & AI Solution of the Year.
Bolton NHS Foundation Trust are the next Trust in Greater Manchester to deploy DERM into their urgent suspected skin cancer pathway.
In this personal account, Stevan shares his experience of AI for skin cancer detection following extensive exposure to the sun during time in the Service and mountaineering.
The Times reports on Chelsea and Westminster Hospital NHS Foundation Trust deploying DERM autonomously, marking a new era for cancer care.
Skin Analytics and Chelsea and Westminster Hospital NHS Foundation Trust win the HSJ Partnership Award 2025 for Most Effective Contribution to Improving Cancer Outcomes.
The Class III CE marking under the European Medical Device Regulation (MDR) 2017/745 reflects the highest level of regulatory scrutiny and underlines DERM’s safety, accuracy and effectiveness in detecting cancer in patients without clinician review. al decisions on skin cancer without oversight marking a transformative era for global healthcare.
In this personal account, Jess shares her experience of the Skin Analytics pathway, what happened after she noticed a lump that had changed and how she felt about AI assessing her skin lesion.
This webinar will showcase real NHS stories and expert insights into how AI as a Medical Device (AIaMD) is transforming dermatology waitlists, improving patient outcomes, and delivering measurable value across trusts.
Hear from NHS colleagues at Chelsea and Westminster Hospital NHS Foundation Trust (CWFT) about how they’re using DERM, the world’s first autonomous AIaMD for dermatology.
In this week’s episode of The Scrubbed In Show podcast, our CEO Neil Daly shares his journey from consulting into building Skin Analytics.
